New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis.

Published in:

PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0250175

By:

• Lusche, Daniel F.;
• Wessels, Deborah J.;
• Reis, Ryan J.;
• Forrest, Cristopher C.;
• Thumann, Alexis R.;
• Soll, David R.

Publication type:

Article